Evidence map›Paper›PMID 34486752›Full record

ArticleInternational journal of cancer2022

Colon fibroblasts from Pirc rats (F344/NTac-Apc

Katia Tortora, Francesca Margheri, Cristina Luceri, Alessandra Mocali, Sara Ristori, Lucia Magnelli, Giovanna Caderni, Lisa Giovannelli

Open access · hybridAbstract read
In one paragraph

Article in International journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Colon fibroblasts from Pirc rats (F344/NTac-ApcInternational journal of cancer · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Katia TortoraNEUROFARBA Department, Pharmacology and Toxicology Section, University of Florence, Florence, Italy.ORCID 0000-0002-0932-9983
Francesca MargheriDepartment of Experimental and Clinical Biomedical Sciences Mario Serio, University of Florence, Florence, Italy.
Cristina LuceriNEUROFARBA Department, Pharmacology and Toxicology Section, University of Florence, Florence, Italy.
Alessandra MocaliDepartment of Experimental and Clinical Biomedical Sciences Mario Serio, University of Florence, Florence, Italy.
Sara RistoriNEUROFARBA Department, Pharmacology and Toxicology Section, University of Florence, Florence, Italy.
Lucia MagnelliDepartment of Experimental and Clinical Biomedical Sciences Mario Serio, University of Florence, Florence, Italy.
Giovanna CaderniNEUROFARBA Department, Pharmacology and Toxicology Section, University of Florence, Florence, Italy.
Lisa GiovannelliNEUROFARBA Department, Pharmacology and Toxicology Section, University of Florence, Florence, Italy.
University of Florence · ITEuropean Society for Sexual Medicine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of fibroblast APC mutation in carcinogenesis is not clear. Apc

Indexed as

Cell ProliferationDNA DamageGenes, APCAnimalsApoptosisColonColonic NeoplasmsFibroblastsInflammationMutationPhenotypeRatsRats, Inbred F344ApcCAFscolon cancercytoplasmic chromatin fociDNA damage response

Identifiers

PMID34486752
PMCPMC9291568
OpenAlexW3196938701

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.